Login / Signup

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2.

Yifan LinJing SunXuezhi CaoXiuye WangXi ChenHairong XuJin-Cun ZhaoYang-Xin FuHua Peng
Published in: Cell discovery (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • dendritic cells
  • protein protein
  • chronic rhinosinusitis
  • amino acid
  • binding protein
  • coronavirus disease
  • immune response